Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for CV Sciences (CVSI) over the last 14 years, with Q3 2025 value amounting to $7.0 million.

  • CV Sciences' Liabilities and Shareholders Equity fell 1663.69% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.6 million, marking a year-over-year decrease of 1233.44%. This contributed to the annual value of $7.9 million for FY2024, which is 1383.7% down from last year.
  • Latest data reveals that CV Sciences reported Liabilities and Shareholders Equity of $7.0 million as of Q3 2025, which was down 1663.69% from $8.0 million recorded in Q2 2025.
  • In the past 5 years, CV Sciences' Liabilities and Shareholders Equity ranged from a high of $30.7 million in Q1 2021 and a low of $7.0 million during Q3 2025
  • Over the past 5 years, CV Sciences' median Liabilities and Shareholders Equity value was $9.9 million (recorded in 2023), while the average stood at $13.6 million.
  • In the last 5 years, CV Sciences' Liabilities and Shareholders Equity tumbled by 4333.69% in 2022 and then tumbled by 832.74% in 2025.
  • Over the past 5 years, CV Sciences' Liabilities and Shareholders Equity (Quarter) stood at $18.1 million in 2021, then dropped by 29.5% to $12.7 million in 2022, then fell by 27.76% to $9.2 million in 2023, then fell by 13.84% to $7.9 million in 2024, then dropped by 11.76% to $7.0 million in 2025.
  • Its Liabilities and Shareholders Equity was $7.0 million in Q3 2025, compared to $8.0 million in Q2 2025 and $7.8 million in Q1 2025.